Role of vehicles in diagnosing contact allergy: An update

Exogenous Dermatology

Volumn 1, Issue 3, 2002, Pages 107-111

  Lee, Ernest E ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergic contact dermatitis; Patch tests; Vehicles

Indexed keywords

1,2 BENZISOTHIAZOLIN 3 ONE; 4 HYDROXYBENZOIC ACID ESTER; ALCLOMETASONE DIPROPIONATE; ALCOHOL; ALLERGEN; BECLOMETASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUDESONIDE; CINNAMALDEHYDE; CLOBETASOL BUTYRATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; DESOXIMETASONE; EUXYL K 400; FLUDROXYCORTIDE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; HALCINONIDE; HYDROCORTISONE BUTYRATE; KATHON CG; LIMONENE; MEPREDNISONE; MINOXIDIL; NEOMYCIN; NICKEL SULFATE; PETROLATUM; TRIAMCINOLONE ACETATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER;

ALLERGY TEST; CONTACT ALLERGY; PATCH TEST; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; STANDARD;

EID: 0037499743     PISSN: 14244616     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063169     Document Type: Review

References (23)

1. Berger TG: Skin, hair and nails; in Tierney LM, McPhee SJ, Papadakis MA (eds): 2001 Current Medical Diagnosis and Treatment. New York, Lange Medical Books, 2001, pp 148-149.
2. Tanglertsampan C, Maibach HI: The role of vehicles in diagnostic patch testing: A reappraisal. Contact Dermatitis 1993;29:169-174.
3. Wilkinson SM, Beck MH, Steel I: Results of patch testing with hydrocortisone butyrate in different vehicles. Contact Dermatitis 2000;42:299-300.
4. Scheman AJ, West DP, Hordinsky MK, Osburn AH, West LE: Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients. Contact Dermatitis 2000;42:241.
5. Reitamo S, Lauerma AI, Forstrom L: Optimal testing for contact allergy to topical corticosteroids; in Frosch PJ, Dooms-Goossens A, Lachappelle J-M, Rycroft RJG, Scheper RJ (eds): Current Topics in Contact Dermatitis. Berlin, Springer, 1989, pp 244-247.
6. Dooms-Goossens A, Paulwels M, Bourda A, Degreef H, Kinget R: Patch testing with corticosteroids in xerogel formulations. Contact Dermatitis 1992;26:206-207.
7. Wilkinson SM, Beck MH: Corticosteroid contact hypersensitivity: What vehicle and concentration? Contact Dermatitis 1996;34:305-308.
8. Grandolfo M, Pipoli M, Foti C, Bonamonte D, Rigano L, Vena GA, Angelini G: Influence of vehicle on patch test response to nickel sulfate. Contact Dermatitis 1996;35:173-174.
9. Warbrick EV, Dearman RJ, Basketter DA, Kimber I: Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/methylisothiazolinone: An analysis using the local lymph node assay. Contact Dermatitis 1999;41:325-329.
10. Chew AL, Maibach HI: 1,2-Benzisothiazolin3-one (Proxel): Irritant or allergen? A clinical study and literature review. Contact Dermatitis 1997;36:131-136.
11. Johansen JD, Andersen KE, Rastogi SC, Menne T: Threshold responses in cinnamicaldehyde-sensitive subjects: Results and methodological aspects. Contact Dermatitis 1996; 34:165-171.
12. Frosch PJ, Pilz B, Andersen KE, Burrows D, Camarase JG, Dooms-Goossens A, Ducombs G, et al: Patch testing with fragrances: Results of a multicenter study of the European Environmental and Contact Dermatitis Research group with 48 frequently used constituents of perfumes. Contact Dermatitis 1995;33:333-342.
13. Tosti A, Vincenzi C, Trevisi P, Guerra L: Euxyl K 400: Incidence of sensitization, patch test concentration and vehicle. Contact Dermatitis 1995;33:193-195.
14. Dooms-Goossens A, Morren M: Results ofroutine patch testing with corticosteroid series in 2,073 patients. Contact Dermatitis 1992;26:182-191.
15. Gross SE, Roberts MS: The effect of occlusion on epidermal penetration of parabens from a commercial allergy test ointment, acetone and ethanol vehicles. J Invest Dermatol 2000;115:914-918.
16. Nilsson U, Magnusson K, Karlberg O, Karlberg A: Are contact allergens stable in patch test preparations? Investigation of the degradation of d-limonene hydroperoxides in petrolatum. Contact Dermatitis 1999;40:127-132.
17. Bjarnason B, Flosadottir E: Patch testing with neomycin sulfate. Contact Dermatitis 2000;43:295-302.
18. Bjarnason B, Flosadottir E: Effect of test techniques on perfusion of neomycin sulfate patch tests. Contact Dermatitis 2000;43:283-294.
19. Bucks D, Maibach HI: Occlusion does not uniformly enhance penetration in vivo; in Bronaugh RL, Maibach HI (eds): Percutaneous Absorption: Drugs - Cosmetics - Mechanisms - Methodology, ed 3, revised and expanded. New York, Dekker, 1999, pp 81-106.
20. Kanerva L, Estlander T, Jolanki R, Alanko K: False-negative patch test reactions due to a lower concentration of patch test substance than declared. Contact Dermatitis 2000;42:289-291.
21. Trattner A, Johansen JD, Menne T: Formaldehyde concentration in diagnostic patch testing: Comparison of 1% with 2%. Contact Dermatitis 1998;38:9-13.
22. De Groot AC: Patch-test concentrations and vehicles for testing contact allergens; in Kanerva L, Elsner P, Wahlberg JE, Maibach HI (eds): Handbook of Occupational Dermatology. Berlin, Springer, 2000, p 1257.
23. Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter D, Wright Z, Marks JG: Contact allergenic potency: Correlation of human and lymph node assay data. Am J Contact Dermatitis 2001;12:156-161.